Filings
Finds words inside filing documents. Searching Aclaris Therapeutics, Inc.'s filings · 45 documents indexed.
7 documents · 28 matches
-
ACRS Aclaris Therapeutics, Inc. 10-K 2026-02-26
Item 1A. Risk Factors
tariffs, the ongoing Section 232 investigations and potential tariffs on pharmaceutical imports could increase our operating costs, disrupt our supply10 matches in this document -
ACRS Aclaris Therapeutics, Inc. 10-Q 2026-11-05
Item 1 · Note 1. Organization and Nature of Business
tariff policies, and inflationary pressures. If the Company is unable to raise sufficient additional capital or generate revenue from transactions3 matches in this document -
ACRS Aclaris Therapeutics, Inc. 10-Q 2026-08-06
Item 1 · Note 1. Organization and Nature of Business
tariff policies, and inflationary pressures. If the Company is unable to raise sufficient additional capital or generate revenue from transactions3 matches in this document -
ACRS Aclaris Therapeutics, Inc. 10-Q 2026-05-07
Item 1 · Note 1. Organization and Nature of Business
tariff policies, and inflationary pressures. If the Company is unable to raise sufficient additional capital or generate revenue from transactions3 matches in this document -
ACRS Aclaris Therapeutics, Inc. 10-Q 2025-11-06
Item 1 · Note 1. Organization and Nature of Business
tariff policies, and the current shutdown of the U.S. federal government. If the Company is unable to raise sufficient additional3 matches in this document -
ACRS Aclaris Therapeutics, Inc. 10-Q 2025-08-07
Item 1 · Note 1. Organization and Nature of Business
tariff policies. If the Company is unable to raise sufficient additional capital or generate revenue from transactions with potential third3 matches in this document -
ACRS Aclaris Therapeutics, Inc. 10-Q 2025-05-08
Item 1 · Note 1. Organization and Nature of Business
tariff policies. If the Company is unable to raise sufficient additional capital or generate revenue from transactions with potential third3 matches in this document
Page 1 of 1 · 7 documents